Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Vitamin A Deficiency : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
Hypothyroidism




Patient Education
Click here for patient education.



Author: Jigna Thakore, MD, Fellow, Department of Gastroenterology, Dayton Veterans Administration Medical Center

Jigna Thakore is a member of the following medical societies: American College of Gastroenterology and American Society of Gastrointestinal Endoscopy

Coauthor(s): N Gopalswamy, MD, Chairman, Department of Gastroenterology, Professor of Internal Medicine, Wright State University / Veterans Affairs Medical Center

Editors: Udaya M Kabadi, MD, Department of Medicine, Professor, University of Iowa School of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Romesh Khardori, MD, Chief, Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Professor, Southern Illinois University School of Medicine; Alex J Mechaber, MD, FACP, Division of General Internal Medicine, Associate Professor, Department of Internal Medicine, University of Miami School of Medicine; George T Griffing, MD, Professor of Medicine, Director of General Internal Medicine, St Louis University

Author and Editor Disclosure

Synonyms and related keywords: VAD, retinoic acid, retinol, beta carotene, beta-carotene, Aquasol A, Palmitate-A, Oleovitamin A, carotenoids, provitamin A, 11-cis-retinol, vision, dark adaptation, nyctalopia, retinol-binding protein, RBP, cellular retinol-binding protein, CRBP, cystic fibrosis, sprue, pancreatic insufficiency, inflammatory bowel disorder, IBD, inflammatory bowel disease, cholestasis, alcoholism, Bitot spots, nyctalopia, dry skin, dry hair, pruritus, broken fingernails, keratomalacia, xerophthalmia, follicular hyperkeratosis, phrynoderma, vitamin deficiency, malnutrition, retinoids, retinoid deficiency, deficiency of vitamin A

Background

The word vitamin was originally derived from Funk's term "vital amine." In 1912, he was referring to Christian Eijkman's discovery of an amine extracted from rice polishings that could prevent beriberi. Funk's recognition of the antiberiberi factor as vital for life was indeed accurate. Researchers have since found that vitamins are essential organic compounds that the human body cannot synthesize. Vitamins A, D, K, and E are classified as fat-soluble vitamins, whereas others are classified as water-soluble vitamins.

Vitamin A was the first fat-soluble vitamin to be discovered. Two independent research teams, Osborne and Mendel at Yale University and McCollum and Davis at the University of Wisconsin, simultaneously discovered it in 1913. Vitamin A comprises a family of compounds called the retinoids. The retinoid designation resulted from finding that vitamin A had the biologic activity of retinol, which was originally isolated from the retina.

In nature, the active retinoids occur in 3 forms: alcohol (retinol), aldehyde (retinal or retinaldehyde), and acid (retinoic acid). The inactive retinoids, known as provitamins A, are produced as plant pigments and are called carotenoids. Several hundred carotenoids occur in foods, but only approximately 50 can be metabolized into the active retinoid forms; among these 50 compounds, beta-carotene, a retinol dimer, has the most significant provitamin A activity.

In the human body, retinol is the predominant form, and 11-cis-retinol is the active form. Retinol-binding protein (RBP) binds vitamin A and regulates its absorption and metabolism. Vitamin A is essential for vision (especially dark adaptation); immune response; epithelial cell growth and repair; bone growth; reproduction; maintenance of the surface linings of the eyes; and epithelial integrity of respiratory, urinary, and intestinal tracts. Vitamin A is also important for embryonic development and regulation of adult genes. It functions as an activator of gene expression by retinoid alpha-receptor transcription factor and ligand-dependent transcription factor.

Deficiency of vitamin A is found among malnourished, elderly, and chronically sick populations in the United States, but it is more prevalent in developing countries. Abnormal dark adaptation, dry skin, dry hair, broken fingernails, and decreased resistance to infections are among the first signs of vitamin A deficiency (VAD).

Pathophysiology

Once ingested, provitamins A are released from proteins in the stomach. These retinyl esters are then hydrolyzed to retinol in the small intestine because retinol is more efficiently absorbed. Carotenoids are cleaved in the intestinal mucosa into molecules of retinaldehyde, which is subsequently reduced to retinol and then esterified to retinyl esters. The retinyl esters of both retinoid and carotenoid origin are transported via micelles in the lymphatic drainage of the intestine to the blood and then to the liver as components of chylomicrons. Of vitamin A in the body, 50-80% is stored in the liver, where it is bound to the cellular RBP. The remaining vitamin A is deposited into adipose tissue, lungs, and kidneys as retinyl esters, most commonly as retinyl palmitate.

Vitamin A can be mobilized from the liver to peripheral tissue by a process of de-esterification of the retinyl esters. In blood, vitamin A is bound to RBP, which transports it as a complex with transthyretin. The hepatic synthesis of RBP is dependent on the presence of zinc and amino acids to maintain its narrow serum range of 40-50 mcg/dL. The retinol is taken up by the peripheral tissues from the RBP-transthyretin complex by a receptor-mediated process.

VAD may be secondary to decreased ingestion, defective absorption and altered metabolism, or increased requirements. An adult liver can store up to a year's reserve of vitamin A, whereas a child's liver may have enough stores to last only several weeks. Serum retinol concentration reflects an individual's vitamin A status. Because serum retinol is homeostatically controlled, its levels do not drop until the body's stores are significantly limited. The serum concentration of retinol is affected by several factors, including RBP synthesis in the liver, infection, nutritional status, and an adequate level of other nutrients such as zinc and iron.

In zinc deficiency, impaired synthesis of proteins occurs with rapid turnover (eg, RBP). In turn, this impairment affects retinol transport by RBP from the liver to the circulation and other tissues. The mechanism by which iron affects vitamin A metabolism has not been identified, but randomized, double-blind studies have shown that vitamin A supplementation alone is not sufficient to improve VAD in the presence of coexisting iron deficiency.

The bioavailability of the carotenoids varies and depends on absorption and their yield of retinol. Only 40-60% of ingested beta-carotene from plant sources is absorbed by the human body, whereas 80-90% of retinyl esters from animal proteins are absorbed. Carotenoid absorption is affected by dietary factors such as zinc deficiency, abetalipoproteinemia, and protein deficiency.

Because vitamin A is a fat-soluble vitamin, any GI diseases affecting the absorption of fats also affect vitamin A absorption. Patients with cystic fibrosis, sprue, pancreatic insufficiency, inflammatory bowel disorder (IBD), cholestasis, and small-bowel bypass surgery are at increased risk for VAD. These patients should be advised to consume vitamin A.

One factor affecting the metabolism of vitamin A is alcoholism. Alcohol dehydrogenase catalyzes the conversion of retinol to retinaldehyde, which is then oxidized to retinoic acid. The affinity of alcohol dehydrogenase to ethanol impedes the conversion of retinol to retinoic acid.

Increased requirements of vitamin A most commonly occur among sick children. In the United States, the American Academy of Pediatrics recommends vitamin A supplementation for infants aged 6-24 months who are hospitalized with measles and for all hospitalized children older than 6 months. In the 1960s, the World Health Organization (WHO) undertook the first global survey of VAD with associated xerophthalmia and complicated measles. In 1973, an international vitamin A board was set up to alleviate global malnutrition. The WHO and United Nations International Children's Emergency Fund (UNICEF) have issued joint statements recommending vitamin A administration for all children, especially those younger than 2 years, who are diagnosed with measles. Coexistent VAD in young children increases the risk of death. The Cochrane Database Systemic Review concluded that daily treatment with 200,000 IU of vitamin A for at least 2 days reduces mortality rates (D'Souza, 2002).

Pregnant women do not require increased vitamin A supplementation. In fact, the Teratology Society advocates that women should be informed of the possible risk of cranial neural crest defects and other malformations resulting from excessive use of vitamin A shortly before or during pregnancy. The recommended daily allowance (RDA) of 800 mcg for all adult females is also appropriate for pregnant women because their stores of vitamin A meet the fetal accretion rate. The requirements for lactating women have been debated, but the current RDA is 1300 mcg in the first 6 months and 1200 mcg in the second 6 months.

The RDAs of vitamin A for various age groups are as follows:

  • Infants aged 1 year or younger - 375 mcg

  • Children aged 1-3 years - 400 mcg

  • Children aged 4-6 years - 500 mcg

  • Children aged 7-10 years - 700 mcg

  • All males older than 10 years - 1000 mcg

  • All females older than 10 years - 800 mcg

Frequency

United States

Statistics from the US Centers for Disease Control and Prevention from the 1988-1991 survey show that age-specific intakes of carotenes were higher among males than females and were higher among adults than children. Significant differences in intake existed among different ethnic groups.

International

Clinical and subclinical VAD are problems in at least 75 countries. In 1994, the WHO classified countries as having clinical or subclinical, severe, moderate, or mild VAD. Most countries with clinical VAD (children demonstrate eye signs and symptoms, including blindness) are in Southeast Asia and sub-Saharan Africa. Severe VAD is also found in persons in refugee settlements and in displaced populations.

Mortality/Morbidity

  • United States: VAD is uncommon in the general population, but subgroups of patients with fat malabsorption, cholestasis, small-bowel bypass, or IBD may have subclinical deficiency with dark-adaptation abnormalities in the range of 60%. Vegans, refugees, persons with alcoholism, toddlers and preschool children living below the poverty line, and recent immigrants or refugees from developing countries all have increased risk of VAD secondary to decreased ingestion.
  • Developing countries: An estimated 250 million children are at risk for vitamin deficiency syndromes. The most widely affected group includes up to 10 million malnourished children who develop xerophthalmia and an increased risk of complications and death from measles. Each year, 250,000-500,000 children become blind because of VAD. Improving the vitamin A status of children with deficiencies (aged 6-59 mo) can reduce rates of death from measles by 50%, rates of death from diarrhea by 33%, and risk rates from of all causes of mortality by 23%.



History

Subclinical forms of VAD may not cause any symptoms, but the risk of developing respiratory and diarrheal infections is increased, the growth rate is decreased, and bone development is slowed. Patients may have a recent history of increased infections, infertility secondary to impaired spermatogenesis, or recent spontaneous abortion secondary to impaired embryonic development. The patient may also report increased fatigue as a manifestation of VAD anemia.

Physical

Signs and symptoms include Bitot spots, poor dark adaptation (nyctalopia), dry skin, dry hair, pruritus, broken fingernails, keratomalacia, xerophthalmia, and follicular hyperkeratosis (phrynoderma) secondary to blockage of hair follicles with plugs of keratin. Other signs include excessive deposition of periosteal bone secondary to reduced osteoclastic activity, anemia, and keratination of mucous membranes.

Causes

The risk of VAD is increased in patients with fat malabsorption, cystic fibrosis, sprue, pancreatic insufficiency, IBD, cholestasis, and/or small-bowel bypass surgery. It is also increased in vegans, refugees, recent immigrants, persons with alcoholism, and toddlers and preschool children living below the poverty line. These patients should be advised to consume vitamin A.



Hypothyroidism

Other Problems to be Considered

Refractory errors
Zinc deficiency



Lab Studies

  • A serum retinol study is a costly but direct measure using high-performance liquid chromatography. A value of less than 0.7 mg/L in children younger than 12 years is considered low.
  • A serum RBP study is easier to perform and less expensive than a serum retinol study because RBP is a protein and can be detected by an immunologic assay. RBP is also a more stable compound than retinol with respect to light and temperature. However, RBP levels are less accurate because they are affected by serum protein concentrations and types of RBP cannot be differentiated.
  • A zinc level is useful because zinc deficiency interferes with RBP production.
  • An iron panel is useful because iron deficiency can affect the metabolism of vitamin A.
  • Albumin levels are indirect measures of vitamin A levels.
  • Obtain a CBC count with differential if anemia, infection, or sepsis is a possibility.
  • An electrolyte evaluation and liver function studies should be performed to evaluate for nutritional and volume status.

Imaging Studies

  • In children, x-ray films of the long bones may be useful to evaluate for bone growth and excessive deposition of periosteal bone.

Procedures

  • Dark-adaptation threshold should be tested.



Medical Care

  • In the United States, VAD can easily be prevented by consuming foods recommended in the Diet section below.
  • Treatment of subclinical VAD includes consumption of vitamin A–rich foods, including liver, beef, chicken, eggs, fortified milk, carrots, mango, sweet potatoes, and leafy green vegetables.
  • For VAD syndromes, treatment includes daily oral supplements of 600 mcg (2000 IU) for children aged 3 years or younger, 900 mcg (3000 IU) for children aged 4-8 years, 1700 mcg (5665 IU) for children aged 9-13 years, 2800 mcg (9335 IU) for persons aged 14-18 years, and 3000 mcg (10,000 IU) for all adults.
  • Therapeutic doses for severe disease include 60,000 mcg (200,000 IU), which has been shown to reduce child mortality rates by 35-70%.

Consultations

  • Consult endocrinologists, gastroenterologists, ophthalmologists, nutritionists, infectious disease specialists, and dermatologists as indicated.

Diet

  • The 2000 US Department of Agriculture and Department of Health and Human Services Dietary Guidelines for Americans recommend consumption of a variety of foods for a comprehensive nutrient intake.
  • Liver, beef, chicken, eggs, whole milk, fortified milk, carrots, mango, orange fruits, sweet potato, spinach, kale, and other green vegetables are among foods rich in vitamin A.
  • Eating at least 5 servings of fruits and vegetable per day is recommended in order to provide a comprehensive distribution of carotenoids.
  • A variety of foods, such as breakfast cereals, pastries, breads, crackers, and cereal grain bars, are often fortified with 10-15% of the RDA for vitamin A.



The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

Drug Category: Vitamins

Essential for normal DNA synthesis and metabolism of proteins, carbohydrates, and fats. May also work as cofactors used in aerobic cellular respiration.

Drug NameVitamin A (Del-Vi-A, Del-Vi-A)
DescriptionCofactor in many biochemical processes.
Adult Dose3000 mcg (10,000 IU) PO qd
Severe disease: 60,000 mcg (200,000 IU) PO for at least 2 d
Pediatric Dose<3 years: 600 mcg (2000 IU) PO qd
4-8 years: 900 mcg (3000 IU) PO qd
9-13 years: 1700 mcg (5665 IU) PO qd
14-18 years: 2800 mcg (9335 IU) PO qd
Severe disease: 60,000 mcg (200,000 IU) PO for at least 2 d
ContraindicationsDocumented hypersensitivity; hypervitaminosis A; pregnancy (if dose >800 mcg/d)
InteractionsCholestyramine, neomycin, and mineral oil may decrease absorption
PregnancyA - Safe in pregnancy
PrecautionsRisk of teratogenicity increases in pregnant women at doses >800 mcg/d (not recommended); parenteral vitamin A in infants of low birth weight may be associated with thrombocytopenia, renal dysfunction, hepatomegaly, cholestasis, ascites, hypotension, and metabolic acidosis (E-Ferol syndrome)



Further Inpatient Care

  • Patients with VAD seldom need to be admitted to the hospital unless they also have a serious associated condition. Patients with sepsis, severe dehydration, and/or metabolic derangements should be admitted to the hospital.

Further Outpatient Care

  • Follow-up care with a primary care physician is recommended.

In/Out Patient Meds

  • Patients should take oral vitamin A at prescribed doses until the deficiency resolves.

Deterrence/Prevention

  • Liver, beef, chicken, eggs, whole milk, fortified milk, carrots, mango, orange fruits, sweet potato, spinach, kale, and other green vegetables are among foods rich in vitamin A.
  • Eating at least 5 servings of fruits and vegetable per day is recommended in order to provide a comprehensive distribution of carotenoids.
  • A variety of foods, such as breakfast cereals, pastries, breads, crackers, and cereal grain bars, are often fortified with 10-15% of the RDA for vitamin A.

Prognosis

  • Prognosis is good if patients are treated when the deficiency is subclinical.
  • Morbidity increases once blindness has progressed or an infection is acquired.
  • Irreversible conditions include punctate keratopathy, keratomalacia, and corneal perforation.

Patient Education

  • Eating at least 5 servings of fruits and vegetable per day is recommended in order to provide a comprehensive distribution of carotenoids.
  • Patients may visit the US National Institutes of Health (NIH) web site for more information (see Facts About Dietary Supplements).



Medical/Legal Pitfalls

  • Evaluation for subclinical symptoms is important in high-risk groups (eg, patients with small-bowel disease or surgery, malabsorption syndromes, alcoholism, or low socioeconomic status). Follow-up care upon completion of all standard vaccination regimens, especially for the measles, is imperative in children.

Special Concerns

  • Studies comparing the association of vitamin A and cancer have yielded mixed results. Two randomized, controlled trials have shown an increased risk of lung cancer associated with beta-carotene supplementation. No convincing data exist concerning a reduction in the risk of colorectal cancer with beta-carotene supplementation. Similarly, clinical data on an association between vitamin A and breast cancer are lacking.



Media file 1:  Clinical signs of Vitamin A deficiency and toxicity.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Graph



  • Alaimo D, McDowell MA, Briefel RR, et al. Dietary Intake of Vitamins, Minerals, and Fiber of Persons Ages 2 Months and Over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. In: Advance Data. Atlanta, Ga: Vital and Health Statistics,. Centers for Disease Control and Prevention;1994:(258) 1-28. Available at: http://www.cdc.gov/nchs/data/ad/ad258.pdf. [Full Text].
  • Combs GF Jr. Vitamins. Chapter 4. In: Mahan LK, Escott-Stump S, eds. Krause's Food, Nutrition, & Diet Therapy. 10th ed. Philadelphia, Pa: WB Saunders; 2000.
  • D'Souza RM, D'Souza R. Vitamin A for treating measles in children. Cochrane Database Syst Rev. 2002;(1):CD001479. [Medline].
  • Department of Health and Human Services, Department of Agriculture. Health and Nutrition: Dietary Guidelines for Americans. Available at: http://www.health.gov/dietaryguidelines/dga2000/document/frontcover.htm. 5th ed. Washington, DC: US Government Printing Office; 2000[Full Text].
  • Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review. JAMA. Jun 19 2002;287(23):3116-26. [Medline].
  • Fletcher RH, Fairfield KM. Vitamin supplementation in disease prevention II. Up To Date. 2002.
  • Munoz EC, Rosado JL, Lopez P, et al. Iron and zinc supplementation improves indicators of vitamin A status of Mexican preschoolers. Am J Clin Nutr. Mar 2000;71(3):789-94. [Medline].
  • NIH Clinical Center. Facts About Dietary Supplements: Vitamin A and Carotenoids. Clinical Nutrition Service. Office of Dietary Supplements. Available at: www.cc.nih.gov/ccc/supplements/vita.html. Bethesda, Md: National Institutes of Health[Full Text].
  • Pazirandeh S, Burns DL. Overview of fat-soluble vitamins I. Up To Date. 2002.
  • Reddy V. History of the International Vitamin A Consultative Group 1975-2000. J Nutr. Sep 2002;132(9 Suppl):2852S-2856S. [Medline].
  • Russell RM. The vitamin A spectrum: from deficiency to toxicity. Am J Clin Nutr. Apr 2000;71(4):878-84. [Medline].
  • Russell RM. Vitamin and trace mineral deficiency and excess. In: Braunwald E, Fauci A, Kasper D, Hauser S, Longo D, Jameson J, eds. Harrison's Principals of Internal Medicine. Vol 1. 15th ed. New York, NY: McGraw-Hill; 2001:. 465-6.
  • World Health Organization. Vitamin A: Advocacy. In: Vitamin A. Available at: http://www.who.int/vaccines-diseases/en/vitamina/advocacy/index.shtml. Geneva, Switzerland: 2003[Full Text].
  • de Pee S, Dary O. Biochemical indicators of vitamin A deficiency: serum retinol and serum retinol binding protein. J Nutr. Sep 2002;132(9 Suppl):2895S-2901S. [Medline].

Vitamin A Deficiency excerpt

Article Last Updated: May 12, 2006